mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
2e-06 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
2e-06 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
4e-06 |
mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
4e-06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
4e-06 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
4e-06 |
mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
6e-06 |
mRNA |
NSC-207895 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
7e-06 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
1e-05 |